Defining and Classifying Cancer Cachexia: A Proposal by the SCRINIO Working Group
- 24 December 2008
- journal article
- research article
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 33 (4) , 361-367
Abstract
Background: Although cancer cachexia is widely diffuse in the cancer patient population, there is no objective definition and classification of this syndrome. The purpose of this study is to propose a simple and quick classification that relies on the severity of the body weight loss and presence/absence of symptoms that are associated with cancer cachexia. Methods: The authors used a database of an ongoing multicenter prospective investigation on the screening of the nutrition risk of 1307 cancer outpatients from different (mainly Italian) university or scientific institutes or hospitals. The database included demographic, oncologic, clinical, and nutrition data. The patients were divided into 4 classes based on combinations of body weight loss (Results: Moving from “asymptomatic precachexia” (class 1) to “symptomatic cachexia” (class 4), there were statistically significant trends (P < .0001) in the percentage of gastrointestinal vs nongastrointestinal tumors, severity of cancer stage, percentage of weight loss, number of symptoms per patient, Eastern Cooperative Oncology Group (ECOG) performance status, and nutritional risk score. Conclusions: The statistical analysis has validated the classification by identifying stages with different severity of cachexia. This classification could be adopted within a comprehensive oncologic approach to the weight‐losing patients, until more specific diagnostic techniques are available in clinical practice.Keywords
This publication has 39 references indexed in Scilit:
- Clinical Benefit With Docetaxel Plus Fluorouracil and Cisplatin Compared With Cisplatin and Fluorouracil in a Phase III Trial of Advanced Gastric or Gastroesophageal Adenocarcinoma: The V-325 Study GroupJournal of Clinical Oncology, 2007
- Dietary Counseling Improves Patient Outcomes: A Prospective, Randomized, Controlled Trial in Colorectal Cancer Patients Undergoing RadiotherapyJournal of Clinical Oncology, 2005
- Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: Effects on survival, metabolism, and functionCancer, 2004
- ESPEN Guidelines for Nutrition Screening 2002Clinical Nutrition, 2003
- Progress in the Management of Gynecologic Cancer: Consensus Summary StatementJournal of Clinical Oncology, 2003
- Impact of fatigue on quality of life in oncology patientsSeminars in Hematology, 2000
- Terminal cancerEuropean Journal of Cancer, 2000
- Definition of standardized nutritional assessment and interventional pathways in oncologyNutrition, 1996
- A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancerCancer, 1990
- Survey of distressing symptoms in dying patients and their families in hospital and the response to a symptom control teamBMJ, 1988